Erythema News and Research

RSS
Vivaglobin therapy effective for patients with primary immunodeficiency

Vivaglobin therapy effective for patients with primary immunodeficiency

Yaupon reports positive results from mechlorethamine gel study for early-stage cutaneous T-cell lymphoma

Yaupon reports positive results from mechlorethamine gel study for early-stage cutaneous T-cell lymphoma

Access enters $30M supply agreement for MuGard with RHEI

Access enters $30M supply agreement for MuGard with RHEI

NIAMS awards $684,000 SBIR grant to Signum Biosciences to develop GPCR modulating therapeutics

NIAMS awards $684,000 SBIR grant to Signum Biosciences to develop GPCR modulating therapeutics

CreAgri receives patent for Hydroxytyrosol for skin damage by UV exposure

CreAgri receives patent for Hydroxytyrosol for skin damage by UV exposure

Diets rich in antioxidants, omega-3 fatty acids can help protect people from skin cancer: Study

Diets rich in antioxidants, omega-3 fatty acids can help protect people from skin cancer: Study

V-101 shows safety profile in treating erythema of rosacea: Clinical study

V-101 shows safety profile in treating erythema of rosacea: Clinical study

JDD publishes long-term efficacy and tolerability study of PyratineXR Moisturizing Lotion

JDD publishes long-term efficacy and tolerability study of PyratineXR Moisturizing Lotion

Shire receives FDA approval of Daytrana for ADHD in adolescents

Shire receives FDA approval of Daytrana for ADHD in adolescents

US WorldMeds launches Revonto for malignant hyperthermia

US WorldMeds launches Revonto for malignant hyperthermia

Vicept completes $16 million Series A financing

Vicept completes $16 million Series A financing

Poster presentation at MASCC Conference summarizes MuGard clinical experience

Poster presentation at MASCC Conference summarizes MuGard clinical experience

NexMed's NexACT-based topical psoriasis treatment bioequivalent to Talconex

NexMed's NexACT-based topical psoriasis treatment bioequivalent to Talconex

AAPA recognizes role of PAs in transforming health care delivery with 2010 PAragon Awards

AAPA recognizes role of PAs in transforming health care delivery with 2010 PAragon Awards

MEDIHONEY dressings serve as low-cost method for treating wounds in indigent patients

MEDIHONEY dressings serve as low-cost method for treating wounds in indigent patients

JAAD publishes Phase III data evaluating safety and efficacy of imiquimod in patients with AK

JAAD publishes Phase III data evaluating safety and efficacy of imiquimod in patients with AK

Phase III study results of Merck's allergy immunotherapy tablet

Phase III study results of Merck's allergy immunotherapy tablet

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

FDA accepts Sol-Gel’s Investigational New Drug Application for DER45-EV Gel

FDA accepts Sol-Gel’s Investigational New Drug Application for DER45-EV Gel

940nm wavelength laser is superior for treating facial spider veins: BUSM researchers

940nm wavelength laser is superior for treating facial spider veins: BUSM researchers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.